Drug Type Small molecule drug |
Synonyms SHR 9549, SHR-9549 |
Target |
Action antagonists |
Mechanism ERs antagonists(Estrogen receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
RegulationSpecial Review Project (China) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
ER-positive/HER2-negative Breast Cancer | Phase 1 | China | 25 Jul 2018 | |
Estrogen receptor positive breast cancer | Phase 1 | China | 25 Jul 2018 | |
HER2-negative breast cancer | Phase 1 | China | 25 Jul 2018 |